On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) 2026 (Final Rule). ...more
11/26/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Filing Requirements ,
Final Rules ,
Health Insurance ,
Healthcare ,
Medicare ,
New Rules ,
OMB ,
Physician Fee Schedule ,
Regulatory Requirements ,
Reporting Requirements
On November 6, 2025, the Centers for Medicare & Medicaid Services (CMS) announced a new drug payment model designed to make Most Favored Nation (MFN)-level prices available to state Medicaid programs via manufacturer rebates....more
11/17/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Health Insurance ,
Healthcare ,
Medicaid ,
Medicaid Drug Rebate Program ,
Most-Favored Nations ,
Pharmaceutical Industry ,
Reporting Requirements ,
Trump Administration
On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) 2026 (Final Rule). It has been several years since this annual rulemaking...more
11/6/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Drug Pricing ,
Final Rules ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Medicaid Drug Rebate Program ,
Medicare ,
Medicare Part B ,
Medicare Part D ,
Physician Fee Schedule ,
Reporting Requirements
On September 30, 2025, the Centers for Medicare & Medicaid Services (CMS) issued final guidance (Final Guidance) for initial price applicability year (IPAY) 2028 of the Inflation Reduction Act (IRA) Drug Price Negotiation...more
10/7/2025
/ Biologics ,
Biosimilars ,
Centers for Medicare & Medicaid Services (CMS) ,
Drug Pricing ,
Health Insurance ,
Healthcare ,
Inflation Reduction Act (IRA) ,
Life Sciences ,
Medicare ,
Medicare Part B ,
Medicare Part D ,
New Guidance ,
Pharmaceutical Industry ,
Prescription Drugs